Lithium

Lithium

SCHEMBL30471801

O=C(O)C1CN(S(=O)(=O)c2ccc(Cl)s2)C1.[Li]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.74
▸ TSHR P16473 1/20 0.74
▸ MMP8 P22894 1/20 0.56
▸ MMP12 P39900 1/20 0.56
▸ MMP13 P45452 1/20 0.56
▸ ALDH1A1 P00352 3/20 0.54
▸ LMNA P02545 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ EPHX2 P34913 1/20 0.46
▸ MAPT P10636 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25989026 0.98 L3MBTL1 (0.76) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL29023287 0.97 L3MBTL1 (0.74) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL5244961 0.85 TSHR (1.00) L3MBTL1TSHRMMP8MMP12MMP13
Lithium Ion SCHEMBL25350249 0.84 L3MBTL1 (0.61) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL24194404 0.82 L3MBTL1 (0.58) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL3717775 0.74 POLB (0.56) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL3719691 0.73 L3MBTL1 (0.52) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL15832924 0.72 MMP8 (0.87) L3MBTL1TSHRMMP8MMP12MMP13
SCHEMBL5245574 0.72 POLB (0.74) L3MBTL1TSHRALDH1A1TDP1SMN1; SMN2
SCHEMBL17147370 0.72 MMP8 (0.57) L3MBTL1TSHRMMP8MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116323606-A Azetidine derivatives for the treatment of integrin-associated diseases 诺丁汉大学 2023-06-23 — — CN disclosed
Send feedback